These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 821268)

  • 1. [Determination and importance of fibrinolytic degradation products in surgical operations].
    Frick VU
    Zentralbl Chir; 1976; 101(5):294-7. PubMed ID: 821268
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quantitative determination of fibrinolytic degradation products by means of electroimmunodiffusion].
    Frick U; Friemel H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(5):826-32. PubMed ID: 4140822
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative assay of fibrinogen and fibrin grafts. Simple radial immunodiffusion and electroimmunoassay (author's transl)].
    Blatný J; Rozprínová L; Fiserová E; Frágner J
    Cas Lek Cesk; 1976 Jul; 115(28):861-4. PubMed ID: 821614
    [No Abstract]   [Full Text] [Related]  

  • 5. [The antifibrinolytic action of the D-dimer fragment].
    Rozenfel'd MA; Khavkina LS; Leonova VB; Gershkovich KB; Vasil'eva MV
    Izv Akad Nauk SSSR Biol; 1989; (6):855-61. PubMed ID: 2621282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma fibrinogen, fibrinolytic activity and serum fibrinogen/fibrin degradation products in ischaemic heart disease.
    Dube B; Somani PN; Tripathi GK; Dube RK; Bhattacharya SK
    J Assoc Physicians India; 1985 Dec; 33(12):784-5, 787. PubMed ID: 3837002
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characteristics of the coagulative and immunological properties of fibrinogen degradation products].
    Fedorova ZD; Paradeeva IK; Zhukova IV; Elizarova AI; Pshenichnaia LN
    Probl Gematol Pereliv Krovi; 1980 Jan; 25(1):44-6. PubMed ID: 6768062
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrinogen fragment D - inhibitor of fibrinolytic processes].
    Rozenfel'd MA; Fateeva LA; Gontar' ID
    Biokhimiia; 1983 Jul; 48(7):1135-40. PubMed ID: 6225469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation between fibrin/fibrinogen degradation products in malignant fluids and the fibrinolytic activity of the peritoneum].
    Takahashi M; Yoshida K; Kano K; Machida T; Nakamura Y; Miura Y; Miura N; Kanno S
    Gan No Rinsho; 1986 Dec; 32(15):1945-9. PubMed ID: 3806965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effect of surgical trauma on rat peritoneal fibrinolytic activity and its role in adhesion formation.
    Hellebrekers BW; Trimbos-Kemper GC; Bakkum EA; Trimbos JB; Declerck PJ; Kooistra T; Emeis JJ
    Thromb Haemost; 2000 Nov; 84(5):876-81. PubMed ID: 11127871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peritoneal mesothelium--the role in fibrin transformations].
    Winckiewicz M; Staniszewski R; Połubińska A; Breborowicz A
    Przegl Lek; 2006; 63(9):778-81. PubMed ID: 17479869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrinogen and fibrin degradation products].
    Fujimaki M; Ikematsu S; Kato M
    Rinsho Byori; 1973 Jan; 21(1):31-6. PubMed ID: 4267650
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinolysis and angiogenesis in wound healing.
    Thompson WD; Harvey JA; Kazmi MA; Stout AJ
    J Pathol; 1991 Dec; 165(4):311-8. PubMed ID: 1723752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin sealants in clinical practice.
    Albala DM
    Cardiovasc Surg; 2003 Aug; 11 Suppl 1():5-11. PubMed ID: 12869982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of the fibrinogen/fibrin antigen content in the blood plasma and serum by radial immunodiffusion].
    Iakunin GA; Smolianitskiĭ AIa; Kurguzova OP; Grabskiĭ MA
    Lab Delo; 1982; (7):408-10. PubMed ID: 6181303
    [No Abstract]   [Full Text] [Related]  

  • 18. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma.
    Carroll RC; Lockhart MS; Taylor FB
    J Lab Clin Med; 1984 May; 103(5):695-703. PubMed ID: 6232329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
    Zhitkova IuV; Aĭsina RB; Varfolomeev SD
    Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.